Skip to main content
Home

Top menu InfoLep

  • About InfoLep

Main navigation

  • Home
  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day 2021
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Antimicrobial resistance in leprosy
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2020
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [3]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NMD Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Zero Leprosy Toolkit
  • Publications
  • Organizations

Top menu - mobile infoLep

  • About InfoLep

Search

Refine your results

Refine your results


Selected filters

  • Reset filters
  • Klingmüller G
  • 1978
  • Lysosomes

Year of Publication

  • 2021 (34)
  • 2020 (1363)
  • 2019 (1198)
  • 2018 (1170)
  • 2017 (1239)
  • 2016 (1373)
  • 2015 (1068)
  • 2014 (893)
  • 2013 (854)
  • 2012 (652)
  • 2011 (597)
  • 2010 (562)
  • 2009 (589)
  • 2008 (550)
  • 2007 (460)
  • 2006 (443)
  • 2005 (443)
  • 2004 (480)
  • 2003 (463)
  • 2002 (389)
  • 2001 (394)
  • 2000 (428)
  • 1999 (443)
  • 1998 (452)
  • 1997 (419)
  • 1996 (412)
  • 1995 (454)
  • 1994 (493)
  • 1993 (477)
  • 1992 (501)
  • 1991 (490)
  • 1990 (511)
  • 1989 (529)
  • 1988 (552)
  • 1987 (504)
  • 1986 (551)
  • 1985 (523)
  • 1984 (496)
  • 1983 (547)
  • 1982 (500)
  • 1981 (440)
  • 1980 (391)
  • 1979 (422)
  • (-) 1978 (347)
  • 1977 (308)
  • 1976 (398)
  • 1975 (331)
  • 1974 (350)
  • 1973 (342)
  • 1972 (315)
  • 1971 (336)
  • 1970 (314)
  • 1969 (286)
  • 1968 (318)
  • 1967 (260)
  • 1966 (281)
  • 1965 (254)
  • 1964 (193)
  • 1963 (145)
  • 1962 (140)
  • 1961 (154)
  • 1960 (175)
  • 1959 (140)
  • 1958 (129)
  • 1957 (168)
  • 1956 (161)
  • 1955 (148)
  • 1954 (147)
  • 1953 (187)
  • 1952 (227)
  • 1951 (205)
  • 1950 (160)
  • 1949 (43)
  • 1948 (88)
  • 1947 (78)
  • 1946 (36)
  • 1945 (9)
  • 1944 (2)
  • 1942 (5)
  • 1941 (1)
  • 1940 (6)
  • 1939 (8)
  • 1938 (8)
  • 1937 (7)
  • 1936 (24)
  • 1935 (6)
  • 1934 (12)
  • 1933 (12)
  • 1932 (7)
  • 1931 (6)
  • 1930 (7)
  • 1929 (11)
  • 1928 (2)
  • 1927 (6)
  • 1926 (8)
  • 1925 (9)
  • 1924 (8)
  • 1923 (2)
  • 1922 (4)
  • 1921 (2)
  • 1920 (4)
  • 1919 (1)
  • 1917 (1)
  • 1916 (2)
  • 1915 (4)
  • 1914 (6)
  • 1913 (2)
  • 1912 (4)
  • 1911 (11)
  • 1910 (6)
  • 1909 (5)
  • 1908 (4)
  • 1907 (1)
  • 1906 (3)
  • 1905 (1)
  • 1904 (4)
  • 1903 (1)
  • 1902 (5)
  • 1901 (2)
  • 1899 (1)
  • 1898 (4)
  • 1897 (4)
  • 1896 (1)
  • 1895 (2)
  • 1893 (2)
  • 1892 (3)
  • 1891 (2)
  • 1890 (7)
  • 1889 (9)
  • 1888 (1)
  • 1886 (1)
  • 1883 (1)
  • 1881 (1)
  • 1880 (1)
  • 1879 (3)
  • 1878 (1)
  • 1877 (3)
  • 1876 (2)
  • 1875 (3)
  • 1874 (1)
  • 1873 (1)
  • 1872 (1)
  • 1870 (4)
  • 1868 (1)
  • 1867 (1)
  • 1866 (1)
  • 1864 (1)
  • 1863 (1)
  • 1861 (1)
  • 1857 (1)
  • 1855 (1)
  • 1847 (1)
  • 1800 (1)
  • 1765 (1)
  • 2 (1)
  • 0 (153)

Research Group

  • LRI / Leprosy Research Initiative
  • IDEAL
  • EUR / Field evaluation of novel immunodiagnostic tools (Jan 2015- Dec 2018)
  • SARI Project (2010-2016)
  • KIT / Treatment of Early Neuropathy in Leprosy Trial (TENLEP) (2010-2016)
  • LSHTM / Development & validation severity scale ENL May 2015 - April 2017
  • IDRI / Integration of rapid diagnostic tests to facilitate case management of leprosy (May 2015 - April 2019)
  • AMC / Role of complement system in nerve damage (2011-2014)
  • LUMC / Immunopathology of leprosy, follow up (2011-2015)
  • Enablement / Inclusion of people with physical disabilities in Nepal
  • LWM / Macro and micro epidemiology of leprosy in Cebu
 
Relevance
Date
No results found.

Use Ris for EndNote, Mendeley, RefWorks, Zotero and most other reference management software.

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications
  • Organizations

Support

  • About Infolep
  • Privacy statement
  • FAQ
  • Contact

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2021 Infolep